Next Article in Journal
Acupotomy in Korean Medicine Doctors: A Preliminary Survey on Experiences, Perceptions, and Clinical Usage Status
Next Article in Special Issue
Blood Cell Ratios Unveiled: Predictive Markers of Myocardial Infarction Prognosis
Previous Article in Journal
State of the Art on Family and Community Health Nursing International Theories, Models and Frameworks: A Scoping Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Development and Validation of the “Hippocratic Hypertension Self-Care Scale”

by
Hero Brokalaki
1,
Anastasia A. Chatziefstratiou
2,*,
Nikolaos V. Fotos
1,
Konstantinos Giakoumidakis
3 and
Evaggelos Chatzistamatiou
4
1
Department of Nursing, School of Health Sciences, National and Kapodistrian University of Athens, 11527 Athens, Greece
2
Cardiac Surgery Unit, Genral Peadiatric Hospital of Athens “Agia Sophia”, 11527 Athens, Greece
3
Department of Nursing, School of Health Sciences, Hellenic Mediterranean University, 71410 Heraklion, Greece
4
Spiliopoulio Hospital of Athens “Saint Elena”, 11521 Athina, Greece
*
Author to whom correspondence should be addressed.
Healthcare 2023, 11(18), 2579; https://doi.org/10.3390/healthcare11182579
Submission received: 14 July 2023 / Revised: 8 September 2023 / Accepted: 16 September 2023 / Published: 18 September 2023
(This article belongs to the Special Issue Current Advances in Cardiovascular Disease)

Abstract

:
Background: The adoption of self-care behaviors among patients with arterial hypertension (AH) plays an important role in the management of their health condition. However, a lack of scales assessing self-care is observed. We aimed to develop and validate the Hippocratic hypertension self-care scale. Methods: From a pool of questions derived from a literature review, 18 items were included in the scale and reviewed by a committee of experts. Participants indicated the frequency at which they followed the self-behavior prescribed in each statement on a five-point Likert scale. Data were collected between April 2019 and December 2019. Results: A total of 202 consecutive adult patients with AH were enrolled in the study. The internal consistency of the scale was found to be 0.807, using Cronbach’s alpha coefficient. An exploratory factor analysis identified two domains that accounted for 92.94% of the variance in the scale items; however, each sub-scale could not be used as an independent scale. Finally, the test–retest of the scale showed a significant strong correlation (r = 0.0095, p < 0.001). Conclusion: This analysis indicates that the scale is reliable and valid for assessing self-care behaviors in patients with AH. It is suggested that health professionals use it in their clinical practice to improve the management of AH.

1. Introduction

Arterial hypertension (AH) is a chronic health condition that may be associated with the development of myocardial disease; stroke; kidney, eye, and vascular diseases. More specifically, the World Health Organization estimates that 54% of strokes and 47% of cases of ischemic heart disease are attributed to high blood pressure. It is estimated that 1.13 billion people worldwide had AH in 2015, whereas over 150 million of them were located in Central and Eastern Europe [1]. The overall prevalence of AH among adults is estimated at around 30–45%, whereas it is approximately 24% in men and 20% in women [1,2]. The prevalence is characterized by a progressive increase with advancing age since more than 60% of people over 60 years old have AH [2]. However, a significant increase in AH prevalence is expected during the next decades because of the population’s age, sedentary lifestyle, and increase in body weight. More specifically, a 15–20% rise is predicted by 2025, which corresponds to 1.5 billion people [3]. In Greece, the prevalence of AH in the general adult population is 41.7%, 45.8% in males, and 37.9% in females [4].
Studies have reported that a reduction in blood pressure (BP) can substantially decrease the total cardiovascular risk as well as all-cause mortality [5]. Also, the reduced incidence of stroke in the last decades can be accounted for, in large measure, by the decrease in blood pressure. The contribution is more significant when baseline BP levels are high. In a meta-analysis of 61 studies involving more than 1 million patients with hypertension, it was observed that a reduction in systolic and diastolic BP reduced cardiovascular events [6]. More specifically, it was found that for people between 40 and 60 years old, a reduction by 20 mmHg in systolic BP is associated with a decrease in risk for stroke and mortality of coronary heart disease. Also, the same effect of a reduction of 10 mmHg in diastolic BP was found. However, it is important to mention that a reduction in BP depends on the level at which patients follow the recommended self-behaviors, such as medication, diet, smoking, alcohol consumption, and exercise [7,8,9]. However, only a minority of patients modify their lifestyle after a diagnosis of AH, and it is hard for them to sustain changes.
Therefore, we reviewed the existing literature through electronic databases to identify the methods used to assess the level of self-behavior among patients with chronic diseases. In the next stage, we reviewed the available scales assessing self-behavior specific in patients with AH. For instance, it is observed that there are plenty of scales assessing the level of adherence to antihypertensive medication only, like the Morisky–Green scale [10], A-14 [11] scale, and Adherence to Refills and Medications Scale (ARMS) [12]. At the same time, we identified the Hill–Bone scale, which aims to evaluate not only adherence to medication but also adherence to salt consumption and appointment-keeping with healthcare providers [13]. It is important to mention that all the above scales are disease-specific for AH; however, none of them evaluates the whole aspects of self-behavior.
Therefore, the aim of the present study was to develop and assess the validity and reliability of the Hippocratic hypertension self-care scale. The goals of the study were the following:
  • Develop the Hippocratic hypertension self-care scale;
  • Examine the reliability of the Hippocratic hypertension self-care scale;
  • Examine the factorial structure of the Hippocratic hypertension self-care scale;
  • Assess the structural estimation modeling approach of the Hippocratic hypertension self-care scale with the use of explanatory factor analysis (EFA).

2. Materials and Methods

2.1. Establishment of Face and Content Validity of the Hippocratic Hypertension Self-Care Scale

Recent data from the literature and reports from international health associations like the European Society of Cardiology and the European Society of Hypertension were reviewed for the development of the scale. During the development of the Hippocratic hypertension self-care scale, an 18-item scale was prepared by the authors, which includes 5 items on medication aspects (items 1–5), 6 items on diet aspects (items 6–11), 1 item on an exercise aspect (item 12), 2 items on alcohol aspects (items 13–14), 1 item on a smoking topic (item 15), 1 item on blood pressure measurement (item 16), and 2 items on appointment keeping (items 17–18). Therefore, the scale includes 7 sub-sections. Each question was encoded in a five-point Likert scale from never (0 points) to very frequently (4 points), with the resulting total summed score ranging between 0 and 72. See Table S1. It is important to clarify that items 1–4, 7–9, 12–15, and 17–18 were to be reverse-scored. As for the score, we used quartiles to organize data into three points—a lower quartile, median, and upper quartile—to form four groups of the dataset. More specifically, a score over 54 was classified as very good, a score between 50 and 54 as good, a score between 45 and 50 as fair, and a score below 45 as poor. Higher scores indicate that patients follow and adopt the recommended self-behaviors.
Ten items questioned how often the patients did not follow the recommended self-behaviors regarding medication, diet, and salt consumption during the last week. Six items examined how often the individuals did not follow the recommended self-behaviors concerning physical activity, alcohol consumption, body weight, smoking, and blood pressure measurement during the last month, while two items questioned how often the patients did not follow the recommended self-behaviors regarding appointment keeping during the last year.
The content validity was assessed through the evaluation of seven experts (two cardiologists, two nurses who specialized in hypertension, one expert in statistics, and two specialists in psychometrics). The professionals graded each question as “essential”, “useful but inadequate”, or “unnecessary”. All questions were assessed for clarity.
As a next step, twenty people without any research background were invited to test the scale for its language and clarity. These persons were not involved in the final sample of the study.

2.2. Study Population and Data Collection

The study was conducted at Hippokration General Hospital, Athens, between April 2019 and December 2019. The sample consisted of 202 men and women who visited the Hypertension Management Unit for their appointment for a routine check-up. The sample size was calculated so that the question item/participant ratio would be at least 1/10. The size of the sample was considered appropriate in order for the results of the present study to be considered adequate. Therefore, healthcare providers could be able to use the Hippocratic hypertension self-care scale without any doubt for the accuracy of their results.
The study included participants with the below criteria:
(1) Age over 18 years old;
(2) Diagnosed AH;
(3) Prescription of at least one antihypertensive drug;
(4) Able to read and write Greek;
(5) Provided written informed consent.
On the other hand, participants with the following criteria were excluded from the study:
(1) The presence of a life-threatening disease;
(2) The presence of a psychiatric disorder;
(3) A history of acute myocardial infarction during the last 2 months or cardiac surgery during the last 6 months.
During the first assessment, the study authors assembled their data via a face-to-face interview. In the second step, the researchers called the participants (n = 30) one month later in order for the sample to re-answer the questions (test–retest reliability). The tool was administered one month after the first assessment, so as to avoid the possibility of participants recalling their answers (memory effect) [14]. The Hippocratic hypertension self-care scale was accomplished for all participants, and demographic characteristics were evaluated. Patients needed 10 min to answer all items on the scale.
All participants enrolled in the study provided written informed consent, after receiving a complete description of the study and having the opportunity to ask for clarification. A cover letter accompanied the questionnaires, explaining the purpose of the study, providing the researchers’ affiliation and contact information, and clearly stating that the answers would be confidential and that anonymity in the final data reports was guaranteed (Ethical Committee’s approval No.: 52/21-12-2017). Participants did not receive any type of remuneration. The investigation conforms to the principles outlined in the Declaration of Helsinki [15].

2.3. Statistics

The mean, standard deviation (SD), median, and interquartile range were used to describe the quantitative data, whereas percentage (%) and frequencies (N) were used for qualitative variables. Reliability coefficients measured by Cronbach’s alpha were calculated for the Hippocratic hypertension self-care scale in order to assess the reproducibility and consistency of the instrument. A Cronbach coefficient alpha value of >0.59 and <0.95 was considered acceptable [15,16]. The underlying dimensions of the scale were checked with an explanatory factor analysis using a Varimax rotation, and the principal components method was used as the usual descriptive method for analyzing grouped data. A factor analysis, using principal component analysis with Varimax rotation, was carried out to determine the dimensional structure of the Hippocratic hypertension self-care scale using the following criteria: (a) eigenvalue > 1; (b) variables should load >0.50 on only one factor and less than 0.40 on other factors; (c) the interpretation of the factor structure should be meaningful; and (d) the scree plot is accurate if the means of commonalities are above 0.60 [16,17]. Bartlett’s test of sphericity with p < 0.05 and a Kaiser–Meyer–Olkin (KMO) measure of sampling adequacy of 0.6 were used in carrying out factor analysis. A factor was addressed as significant whether its eigenvalue exceeded 1.0 [16].
A correlation analysis was used to assess internal consistency reliability. The correlation coefficient should not be negative or below 0.20 [18]. Pearson’s rank correlation coefficient was used to check the level of agreement between responses at the test and re-test. Also, a linear regression model with the level of adherence as the dependent variable and one independent variable was used to estimate the correlation between the level of adherence and the added independent variable. The level of significance was 0.05. The analysis was conducted via SPSS 19.0.

3. Results

The demographic and clinical characteristics of the sample are presented in Table 1 and Table 2. Almost 55.0% of the sample was women, whereas the mean age was 66.9 years old (range: 30–93 years old). Most participants were divorced or widowed (80.7%), 40.0% had a higher educational level, whereas only 33.2% were employees. More than half the patients had AH stages I or II. The most common self-reported comorbidities were diabetes mellitus (43.4%) and respiratory disease (52.5%).
The median score and the quartiles of all Hippocratic hypertension self-care scale questions are presented in Table 3. The commonalities for the Hippocratic hypertension self-care scale questions are presented in Table 4. The internal consistency characteristics of the Hippocratic hypertension self-care scale showed good reliability, as Cronbach’s alpha was 0.807 for the total scale (items 1–18).
The KMO measure of sampling adequacy was 0.653 and Bartlett’s test of sphericity was 1993.02, df = 153, p < 0.001. Factor analysis indicated that there are two principal factors in the model, and these accounted for 92.94%, as presented in Table 5. The first factor (F1) includes the following items: 1 (forget to take medication), 2 (omit to take medication due to its side effects), 3 (omit to take medication when patients feel better), 4 (omit to take medication when patients are outside/travel), and 5 (change the doses according to recommendations); this was termed “Medication aspects”. The second factor (F2) consists of the following items: 6 (daily consumption of fruit and vegetables), 7 (consumption of food responsible for weight increase), 8 (consumption of salty food), 9 (shake salt on your food), 10 (read food labels for ingredients), and 11 (try to lose or maintain body weight); this was termed “Diet aspects”. Cronbach’s alpha was 0.591 and 0.375 for F1 and F2, respectively.
The Hippocratic hypertension self-care scale was well accepted by the participants since it was simple and needed only 10 min to be answered. The items were assessed as relevant, reasonable, unambiguous, and clear. Therefore, face validity was considered very good. According to the test–retest, a high positive correlation was found between the total scores of the assessments (r = 0.995; p < 0.001).
The total score on the Hippocratic hypertension self-care scale was significantly lower in patients with less controlled AH (t = 2.168; p = 0.036). In addition, the score for the medication sub-scale was significantly higher among participants with less controlled AH (t = 0.744; p = 0.012), and the score in the diet subdimension was higher in patients with dyslipidemia (t = 0.658; p = 0.013). According to correlation analysis, the level of self-behavior was not associated with age (r = −0.781; p > 0.05), gender (t = 0.427; p > 0.05), and education level (p > 0.05). However, the total score on the Hippocratic hypertension self-care scale was related to the presence of comorbidities and damages in other organs (p < 0.01).

4. Discussion

The Hippocratic hypertension self-care scale is a non-generic, disease-specific instrument for assessing self-behaviors among patients with AH. Our validation analysis gave a Cronbach’s alpha of 0.807 for the entire scale, whereas the factor analysis detected two main factors; however, further analysis did not show a satisfactory Cronbach’s alpha for these two factors. These domains accounted for 92.94% of the total variance.
To our knowledge, this is the first study to develop a scale assessing all aspects of self-behaviors in patients with AH, which should, therefore, be incorporated into research and clinical practice in order to assess the effectiveness of the provided healthcare and the need for individualized educational intervention. For instance, the Hypertension Self-Care Activity Level Effects (H-SCALE) and Self-Care of Hypertension Inventory (SC-HI) scales assess only the aspects of medication, diet, exercise, body weight, alcohol, and smoking [19,20]. The Hypertension Self-Care Profile (HBP SCP) encompassed the following self-care behaviors: taking medication and lifestyle factors such as exercise, diet, alcohol consumption, non-smoking, self-monitoring of BP, weight control, regular doctor visits, and stress management [21].
The overall Cronbach’s alpha of 0.807 was decoded as high internal consistency for the scale [16,17]. It is essential to mention that the Cronbach’s alpha value was very low for the sub-scales of “Medication”, “Diet”, and “Alcohol”, whereas it could not be calculated for the sub-scales of “Smoking”, “Blood pressure measurement”, and “Exercise” since they included only one item. On the other hand, Cronbach’s alpha was 0.807 for the “Appointment keeping” sub-scale. Therefore, it is clear that the Hippocratic hypertension self-care scale is recommended for use as an entire scale, and each sub-scale is not recommended for use as an independent scale.
The factor analysis of the Hippocratic hypertension self-care scale loaded all items and gave two factors: the “Medication Aspects” (Q1–Q5) and the “Diet Aspects” (Q6–Q11). These two factors account for 92.94% of the total variance. This could be explained by the fact that each sub-section of “Smoking”, “Exercise”, and “Blood pressure measurement” includes only one item, whereas the sub-sections of “Appointment keeping” and “Alcohol consumption” include only two.
Our study provides a significant advantage since the score of the Hippocratic hypertension self-care scale is classified into categories so that healthcare providers can assess the degree to which patients follow the recommended self-behaviors. More specifically, a score over 54 is classified as very good, which means that patients adopt almost all the recommended self-behaviors, a score between 50 and 54 is classified as good, a score between 45 and 50 is classified as fair, and a score below 45 is classified as poor, indicating that patients tend not to follow the recommended self-behaviors.
As for the test–retest, the research team administered the questionnaire two times to the study sample under the same conditions, with an interval of one month. Statistically significant results for the test–retest reliability assessment of the Hippocratic hypertension self-care scale were found during the analysis. More specifically, the correlation coefficient was r = 0.995, which proves the stability of the scale over time (p < 0.001).
The results indicated that the total score on the Hippocratic hypertension self-care scale was significantly lower in patients with less controlled AH (t = 2.168; p = 0.036). This finding is totally explained since recommendations for lifestyle changes could lead to a significant reduction in BP [22]. More specifically, a low level of score in the subscales of medication and diet is related to a high possibility of uncontrolled AH and dyslipidemia, respectively. Finally, according to correlation analysis, the level of self-behavior was not associated with age (r = −0.781; p > 0.05), gender (t = 0.427; p > 0.05), and education level (p > 0.05). This fact permits the administration of the Hippocratic hypertension self-care scale to the whole population with AH independently of their demographic characteristics.
On the other hand, the total score on the Hippocratic hypertension self-care scale was related to the presence of comorbidities and damages in other organs (p < 0.01). Firstly, patients with comorbidities or damage in other organs experience symptoms of many systems and they have to adopt and follow different self-behaviors for each separate health condition. Therefore, the complication of their therapeutic regimen is a burden to them and their level of self-behavior is very low.
The Hippocratic hypertension self-care scale is suggested to be applied in daily clinical practice and may allow healthcare providers to implement specific interventions in order to improve patients’ everyday lives and management of arterial hypertension, rather than focusing solely on the treatment of the specific side effects of the disease.
Our study had some limitations. Firstly, the Hippocratic hypertension self-care scale is a self-administered tool; therefore, information bias could affect the results. Also, we did not conduct ROC analysis due to the lack of a gold-standard tool.

5. Conclusions

The Hippocratic hypertension self-care scale showed satisfactory reliability, and the factor analysis indicated two factors that were of interest. We can, therefore, assert that it is a reliable and valid tool for identifying self-behaviors among patients with arterial hypertension. The score of the scale is independent of the demographic characteristics of people with AH; therefore, it could be used for any patient with AH without any limitation. Healthcare providers can use it in their clinical practice to enhance the identification of patients who do not follow and adopt the recommended self-behaviors. Future cross-sectional and cohort studies are suggested so as to inform clinical practicians and guide the development of specific interventions for self-behaviors among patients with arterial hypertension.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/healthcare11182579/s1, Table S1: Hippocratic hypertension self-care scale.

Author Contributions

Conceptualization, H.B.; methodology, H.B. and A.A.C.; software, A.A.C. and N.V.F.; validation, K.G. and A.A.C.; formal analysis, A.A.C.; investigation, H.B., A.A.C. and N.V.F.; data curation, E.C. and A.A.C.; writing—original draft preparation, K.G., N.V.F., A.A.C. and H.B.; writing—review and editing, K.G. and A.A.C.; supervision, H.B.; project administration, H.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of General Hospital of Athens “Hippokration” (Ethical Committee’s approval No.: 52/21-12-2017).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. Written informed consent was obtained from the patients to publish this paper.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 2007, 389, 37–55. [Google Scholar]
  2. Chow, C.K.; Teo, K.K.; Rangarajan, S.; Islam, S.; Gupta, R.; Avezum, A.; Bahonar, A.; Chifamba, J.; Dagenais, G.; Diaz, R.; et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013, 310, 959–968. [Google Scholar] [CrossRef] [PubMed]
  3. Kearney, P.M.; Whelton, M.; Reynolds, K.; Muntner, P.; Whelton, P.K.; He, J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005, 365, 217–223. [Google Scholar] [CrossRef] [PubMed]
  4. Hellenic Health Foundation. HYDRIA. Program and Targeted Action on the Health and Nutrition of the Greek Population: Development and Implementation of Methodology and Documentation; Hellenic Health Foundation: Athina, Greece, 2016. [Google Scholar]
  5. Lewington, S.; Clarke, R.; Qizilbash, N.; Peto, R.; Collins, R.; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360, 1903–1913. [Google Scholar] [PubMed]
  6. Turnbull, F.; Neal, B.; Algert, C.; Chalmers, J.; Chapman, N.; Cutler, J.; Woodward, M.; MacMahon, S.; Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: Results of prospectively designed overviews of randomized trials. Arch. Intern. Med. 2005, 165, 1410–1419. [Google Scholar] [PubMed]
  7. Choi, H.Y.; Oh, I.J.; Lee, J.A.; Lim, J.; Kim, Y.S.; Jeon, T.H.; Cheong, Y.S.; Kim, D.H.; Kim, M.C.; Lee, S.Y. Factors Affecting Adherence to Antihypertensive Medication. Korean J. Fam. Med. 2008, 39, 325–332. [Google Scholar] [CrossRef] [PubMed]
  8. Vallée, A.; Gabet, A.; Deschamps, V.; Blacher, J.; Olié, V. Relationship between Nutrition and Alcohol Consumption with Blood Pressure: The ESTEBAN Survey. Nutrients 2019, 11, 1433. [Google Scholar] [CrossRef] [PubMed]
  9. Akbarpour, S.; Khalili, D.; Zeraati, H.; Mansournia, M.A.; Ramezankhani, A.; Ahmadi Pishkuhi, M.; Rostami Gooran, S.; Fotouhi, A. Relationship between lifestyle pattern and blood pressure—Iranian national survey. Sci. Rep. 2019, 9, 15194. [Google Scholar] [CrossRef] [PubMed]
  10. Morisky, D.E.; Ang, A.; Krousel-Wood, M.; Ward, H.J. Predictive validity of a medication adherence measure in an outpatient setting. J. Clin. Hypertens. 2008, 10, 348–354. [Google Scholar] [CrossRef] [PubMed]
  11. Jank, S.; Bertsche, T.; Schellberg, D.; Herzog, W.; Haefeli, W.E. The A14-scale: Development and evaluation of a questionnaire for assessment of adherence and individual barriers. Pharm. World Sci. 2009, 31, 426–431. [Google Scholar] [CrossRef] [PubMed]
  12. Chen, Y.J.; Chang, J.; Yang, S.Y. Psychometric Evaluation of Chinese Version of Adherence to Refills and Medications Scale (ARMS) and Blood-Pressure Control Among Elderly with Hypertension. Patient Prefer. Adherence 2020, 14, 213–220. [Google Scholar] [CrossRef]
  13. Kim, M.T.; Hill, M.N.; Bone, L.R.; Levine, D.M. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog. Cardiovasc. Nurs. 2020, 15, 90–96. [Google Scholar] [CrossRef]
  14. Galanis, P. Validity and reliability of questionnaires in epidemiological studies. Arch. Hellen. Med. 2013, 30, 97–110. [Google Scholar]
  15. Rickham, P.P. Human experimentation. Code of ethics of the world medical association. Declaration of helsinki. Br. Med. J. 1964, 2, 177. [Google Scholar] [PubMed]
  16. Powers, B.; Knapp, T. Dictionary of Nursing Theory and Research; Springer Publishing Company: New York, NY, USA, 2005. [Google Scholar]
  17. Brink, J.; Wood, J. Advanced Design in Nursing Research, 2nd ed.; Sage Publication: Thousand Oaks, CA, USA, 1998. [Google Scholar]
  18. Cam, M.O.; Arabaci, L.B. Qualitative and quantitative steps on attitude scale. Turk. J. Res. Dev. Nurs. 2010, 2, 59–71. [Google Scholar]
  19. Warren-Findlow, J.; Basalik, D.W.; Dulin, M.; Tapp, H.; Kuhn, L. Preliminary validation of the Hypertension Self-Care Activity Level Effects (H-SCALE) and clinical blood pressure among patients with hypertension. J. Clin. Hypertens. 2023, 15, 637–643. [Google Scholar] [CrossRef] [PubMed]
  20. Silveira LC, J.; De Maria, M.; Dickson, V.V.; Avila, C.W.; Rabelo-Silva, E.R.; Vellone, E. Validity and reliability of the self-care of hypertension inventory (SC-HI) in a Brazilian population. Heart Lung J. Crit. Care 2020, 49, 518–523. [Google Scholar] [CrossRef] [PubMed]
  21. Han, H.R.; Lee, H.; Commodore-Mensah, Y.; Kim, M. Development and validation of the Hypertension Self-care Profile: A practical tool to measure hypertension self-care. J. Cardiovasc. Nurs. 2014, 29, E11–E20. [Google Scholar] [CrossRef] [PubMed]
  22. Mancia Chairperson, G.; Kreutz Co-Chair, R.; Brunström, M.; Burnier, M.; Grassi, G.; Januszewicz, A.; Muiesan, M.L.; Tsioufis, K.; Agabiti-Rosei, E.; Algharably, E.A.E.; et al. 2023 ESH Guidelines for the Management of Arterial Hypertension the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J. Hypertens. 2023. Online ahead of print. [Google Scholar] [CrossRef]
Table 1. Demographic characteristics of patients.
Table 1. Demographic characteristics of patients.
CharacteristicN (%)
Gender
 Male91 (45.0)
 Female111(55.0)
Age (years)66.9 (11.70)
Education level
 Compulsory60 (29.7)
 Intermediate60 (29.7)
 Secondary/university82 (40.6)
Marital status
 Married28 (13.9)
 Divorced/widower163 (80.7)
 Unmarried11 (5.4)
Living conditions
 Alone17 (8.4)
 Family/relation/other support network185 (91.6)
Employment status
 Employed67 (33.2)
 Unemployed88(43.6)
 Retired31 (15.3)
 Household16 (7.9)
Table 2. Clinical characteristics and habits of patients.
Table 2. Clinical characteristics and habits of patients.
CharacteristicN (%)
Damage in target organs
 Stroke15 (6.6)
 Stable angina8 (3.5)
 Unstable angina8 (3.5)
 Acute myocardial infarction4 (1.8)
 Retinopathy9 (3.9)
Comorbidity
 Diabetes mellitus87 (43.4)
 Heart failure20 (9.9)
 Respiratory disease106 (52.5)
 Kidney disease3 (1.48)
 Musculoskeletal disease35 (17.3)
Classification of hypertension according to ESH
 I72 (35.6)
 II77 (38.1)
 III29 (14.4)
 Isolated systolic hypertension24 (11.9)
Systolic blood pressure(mmHg)142 (15.88)
Diastolic blood pressure(mmHg)86 (10.71)
Blood glucose106 (36.6)
LDL119 (41.6)
HDL46 (12.7)
BMI (kg/m2)22.5 (4.73)
Smoking
 Yes26 (11.4)
 No176 (87.1)
Daily alcohol consumption
 Yes26 (11.4)
 No176 (87.1)
ESH: European Society of Hypertension, LDL: low-density lipoprotein, HDL: high-density lipoprotein, BMI: body mass index.
Table 3. Median and quartiles (q25, q75) of the 18 Hippocratic hypertension self-care scale items.
Table 3. Median and quartiles (q25, q75) of the 18 Hippocratic hypertension self-care scale items.
ItemMedianq25q75
Q14.003.004.00
Q23.001.004.00
Q33.000.004.00
Q43.000.004.00
Q51.000.003.25
Q62.001.004.00
Q72.001.002.25
Q82.001.753.00
Q92.000.754.00
Q100.500.003.00
Q112.501.004.00
Q122.001.003.25
Q133.501.004.00
Q143.001.004.00
Q154.000.004.00
Q162.001.003.00
Q174.001.504.00
Q180.000.000.00
Table 4. Correlation of each item score with their total scores.
Table 4. Correlation of each item score with their total scores.
Q1Q2Q3Q4Q5Q6Q7Q8Q9Q10Q11Q12Q13Q14Q15Q16Q17Q18
Q11.000
Q20.3311.000
Q30.1910.6461.000
Q40.1440.6340.9791.000
Q50.1500.3830.0990.1111.000
Q60.2020.0000.005−0.0150.3521.000
Q70.1290.3920.3600.3150.4950.4101.000
Q80.2920.5720.2390.2230.4370.1280.5311.000
Q90.1520.5040.4750.4900.158−0.2050.1770.4751.000
Q100.0270.000−0.201−0.2040.1410.0680.2760.3130.0901.000
Q110.1410.082−0.061−0.1110.1810.3670.2010.318−0.0470.0921.000
Q120.3220.5690.4910.4950.2490.1220.3600.4220.579−0.0540.3431.000
Q13−0.0290.6790.4860.4250.062−0.1340.1110.2080.192−0.099−0.0160.2031.000
Q140.3160.5830.3200.2540.1780.1510.3260.4160.3970.0880.0560.3940.5521.000
Q150.1820.3060.3440.2500.038−0.0010.2800.1960.1060.0470.0530.3570.4380.5141.000
Q160.2970.128−0.200−0.1790.3150.3070.2280.4710.2740.2770.4700.295−0.1450.079−0.1171.000
Q17−0.1870.2700.2440.2180.042−0.0110.062−0.095−0.0240.030−0.327−0.2610.3020.1070.164−0.5121.000
Q18−0.1700.2900.2940.2810.092−0.0340.1200.0140.195−0.156−0.269−0.1870.2190.0900.004−0.3540.7741.000
Table 5. Exploratory factors and explained variance after rotation for the Hippocratic hypertension self-care scale.
Table 5. Exploratory factors and explained variance after rotation for the Hippocratic hypertension self-care scale.
Factors Rotation Sums of Squared Loadings
Rescaled LoadingEigenvalues% of VarianceCumulative VarianceCronbach’s Alpha
Factor 1Factor 2Factor 3Factor 4Factor 5Factor 6Factor 7
Factor 1Question 10.9140.9170.0790.0510.2200.1060.0720.05267.0167.010.591
Question 20.8660.8670.1660.1110.2250.1150.1050.100
Question 30.8780.8870.0180.1080.2500.0870.0940.064
Question 40.9240.9120.0660.1190.1660.1880.1010.100
Question 50.6420.6750.1460.1040.2100.1020.3140.214
Factor 2Question 60.6680.4320.0200.5440.3050.2470.1730.10325.9792.940.375
Question 70.6950.2380.3620.1570.1620.4370.5160.416
Question 80.7960.0930.6680.1150.1340.4870.2710.171
Question 90.7920.1690.4950.4830.2180.1030.4760.276
Question 100.5830.0930.4770.4940.0850.0730.3010.100
Question 110.6410.2320.5280.3630.3040.0920.2740.074
Factor 3Question 120.6090.2360.5240.3600.3250.0170.2070.102
Factor 4Question 130.7330.0040.4200.4350.1600.5820.0560.036 0.557
Question 140.5990.2110.1610.3030.2490.5790.1990.107
Factor 5Question 150.4850.0780.0090.1960.1100.4490.4770.208
Factor 6Question 160.7000.3410.5990.2370.3940.1100.0330.013
Factor 7Question 170.8510.2520.0410.4970.7040.1740.1130.103 0.807
Question 180.8260.4270.0020.3680.6430.1900.2410.141
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Brokalaki, H.; Chatziefstratiou, A.A.; Fotos, N.V.; Giakoumidakis, K.; Chatzistamatiou, E. The Development and Validation of the “Hippocratic Hypertension Self-Care Scale”. Healthcare 2023, 11, 2579. https://doi.org/10.3390/healthcare11182579

AMA Style

Brokalaki H, Chatziefstratiou AA, Fotos NV, Giakoumidakis K, Chatzistamatiou E. The Development and Validation of the “Hippocratic Hypertension Self-Care Scale”. Healthcare. 2023; 11(18):2579. https://doi.org/10.3390/healthcare11182579

Chicago/Turabian Style

Brokalaki, Hero, Anastasia A. Chatziefstratiou, Nikolaos V. Fotos, Konstantinos Giakoumidakis, and Evaggelos Chatzistamatiou. 2023. "The Development and Validation of the “Hippocratic Hypertension Self-Care Scale”" Healthcare 11, no. 18: 2579. https://doi.org/10.3390/healthcare11182579

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop